27.07.22|Sophie ShulmanThe settlement removes the cloud of uncertainty that hovered over Teva, which on the one hand prevented investors from placing trust in its stock, while on the other hand also prevented Teva management from making substantial moves
27.07.22|Sophie Shulman and ReutersTeva is set to pay state and local governments up to $3.7 billion in cash over 13 years plus a contribution of $1.2 billion worth of the opioid overdose reversal drug naloxone
18.08.20|CTechGovernor Andrew M. Cuomo announced that the New York State Department of Financial Services has initiated administrative proceedings against Teva in connection with the Opioid Crisis
22.10.19|Lilach BaumerTeva announced on Monday a settlement with both Cuyahoga and Summit counties of Ohio, averting the trial scheduled for later that day, and an agreement in principle for a global settlement framework
16.10.19|Hezi SternlichtThe Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court
13.10.19|CTechTeva made a last minute attempt to be tried separately in opioid abuse damages case set to be held on October 21 in federal court in Cleveland, Ohio
25.06.19|Hezi SternlichtThe settlement will see Teva will pay Oklahoma a one-time payment of $85 million to settle claims that it had played a role in exacerbating the U.S. opioid use epidemic there
19.05.19|Adrian FilutBetween 2011 and 2016, the availability of opioids in Israel grew by 125%, according to an OECD report published over the weekend
21.04.19|Lilach BaumerCommonly known as Narcan, the spray is considered a life-saving medication, and Teva’s drug is the first generic product approved that does not require medical training to use
31.03.19|Amitai Gazit and Lilach BaumerEarlier this month, Teva agreed to sell the land tenure rights of its two Jerusalem factories, set to close by the end of 2019, for a combined $77 million